Aginko Research AG

Aginko Research AG Aginko is the Credit Impot Recherche accredited CRO specialized in osteoarticular pathologies and medical devices We help create maximum value for your company.

Our Vision is to be the CRO of choice for all Musculosketal Research Projects from pre-clinical to clinical and regulatory studies, helping musculoskeletal companies achieve maximum value for all stakeholders. AGINKO’s mission is to provide the best quality pre-clinical laboratory services and clinical trial management for our clients in the pharmaceutical, biotechnological and medical device industries. This mission is achieved through our commitment to customer service and scientific quality. We employ a team of experienced musculoskeletal experts who help guide your orthopaedic products or compounds through the regulatory pre-clinical and clinical processes quickly and successfully.

Aginko's pathology and histology experts offer preclinical histopathology of COVID VaccinesPreclinical histopathology of...
18/06/2020

Aginko's pathology and histology experts offer preclinical histopathology of COVID Vaccines

Preclinical histopathology of vaccine candidates focuses on safety of the vaccine by evaluating tissue changes after administration in animals, not only on the site of administration but in all other tissue to make sure there are not unwanted consequences.
Aginko's pathologists assess safety changes associated with vaccination protocols.

Aginko Research wishes you all a happy Easter !!! And stay safe.
09/04/2020

Aginko Research wishes you all a happy Easter !!!

And stay safe.

Update on Aginko activities - COVID 19Dear Clients and Partners, As promised, we are continuing to keep you updated on A...
02/04/2020

Update on Aginko activities - COVID 19

Dear Clients and Partners,

As promised, we are continuing to keep you updated on Aginko's activities during these unprecedented times.
Aginko's concern, first and foremost, is for the health and safety of our collaborators, consultant and clients.
Even, if some of the futures projects are in stand-bay for instance, our team is working on ongoing projects, shifting to a home-based work model and limited presence in our laboratories.

Moreover, this period motivated to overcome ourselves in order to find new solutions trying to combat the COVID-19 pandemic situation.

Thus, Aginko has already developed two products that are intended to prevent the spread of this type of virus and will continue to innovate in order to set up a contengy plan.

We can start already to disscus and prepare with you on our preclinical models dedicated to test future medical devices and treatments develped to eliminate COVID-19 or our core excellence, OA, Cartilage, RA, Pain, Bone fracture Medical devices testing or histological services.

There is no better time to strengthen our bonds, to help each other through this storm and come out the other side stronger.
Take care of yourself and your loved ones !

Yours Faithfully,

Your Aginko team.

Aginko can support your  , discover our wide choice of     :  www.aginko.com
23/01/2020

Aginko can support your , discover our wide choice of : www.aginko.com

  at the John Hopkins University School of Medicine say they have added to the evidence that age-related changes to     ...
15/01/2020

at the John Hopkins University School of Medicine say they have added to the evidence that age-related changes to tissue could invite painful nerve overgrowth that causes lower back .
Read full article : https://go.nature.com/35WSHiG.
Aginko can support your research, visit our website for more information: www.aginko.com

Spinal pain is a major clinical problem. Here the authors show that osteoclasts create porous area of endplates of the vertebrae and sensory innervation of porous endplates by Netrin-1 release from osteoclasts mediates PGE2-induced spinal hypersensitivity in mice.

Aginko Research AG wishes you a Wonderful Holiday Season and a Happy New Year !
30/12/2019

Aginko Research AG wishes you a Wonderful Holiday Season and a Happy New Year !

Merry Christmas from the Aginko Research AG Team ! We hope you have a wonderful festive season !
23/12/2019

Merry Christmas from the Aginko Research AG Team ! We hope you have a wonderful festive season !

Substantive molecular and   changes within the meniscus with tears. Read more : https://bit.ly/2LLQIX5.Aginko can suppor...
11/12/2019

Substantive molecular and changes within the meniscus with tears. Read more : https://bit.ly/2LLQIX5.
Aginko can support your research, visit our website for more information: www.aginko.com

This   quantify sensory and motor deficits in  collagen-induced   ( )   during natural disease progression and therapeut...
06/12/2019

This quantify sensory and motor deficits in collagen-induced ( ) during natural disease progression and therapeutic treatment. Read full article : https://bit.ly/2DYeril.
Aginko can support your research, visit our website for more information: www.aginko.com

In the collagen-induced arthritis (CIA) mouse model, inflammation readouts are usually quantified using operator-dependent clinical scoring systems, and no systematic relationship with functional deficits has been detected. In this study, we extensively quantified sensory and motor deficits in CIA m...

Bone marrow mesenchymal stem cells in    , spondyloarthritis, and ankylosing spondylitis: problems rather than solutions...
15/11/2019

Bone marrow mesenchymal stem cells in , spondyloarthritis, and ankylosing spondylitis: problems rather than solutions? Read full article : https://bit.ly/2XghPhy
Aginko can support your research, visit our website for more information: www.aginko.com

Bone marrow mesenchymal stem cells (BM-MSCs) can dampen inflammation in animal models of inflammatory rheumatisms and human osteoarthritis. They are expected to be a solution for numerous human conditions. However, in rheumatoid arthritis (RA) and spondyloarthritis (SpA), subsets of subchondral BM-M...

This article shows that virtual reality can be used to reduce   sensitivity. Read full article : https://bit.ly/2K9PpQP....
12/11/2019

This article shows that virtual reality can be used to reduce sensitivity. Read full article : https://bit.ly/2K9PpQP.
Aginko can support your research, visit our website for more information: www.aginko.com

Watching immersive 360 videos of icy Arctic scenes helps to relieve burning pain and could hold hope for treating chronic pain, a study has found.

Identifying the role of Asporin (ASPN) and Cartilage oligomeric matrix protein (COMP) ) genes in     development. Read f...
05/11/2019

Identifying the role of Asporin (ASPN) and Cartilage oligomeric matrix protein (COMP) ) genes in development. Read full article : https://bit.ly/2oS5Wlg.
Aginko can support your research, visit our website for more information: www.aginko.com

Adresse

Route De L'ancienne Papeterie 7
Marly-le-Grand
1723

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Aginko Research AG erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Your Partner of Choice for Projects in Bone and Joint Diseases

AGINKO Research is a unique osteoarticular and inflammation focused preclinical and clinical research organization with an unrivaled reputation for conducting global studies and development programs of the highest integrity.

Our clients (pharmaceutical, biotechnology and medical device companies) rely on us to conduct world-class preclinical and clinical programs in the field of bone, cartilage, spine, inflammation, and pain.

In these areas, in particular, we offer broad study experience and direct knowledge of study requirements, risk management, and best practice implementation.

We offer effective study design and management services, multi-service integration, and an efficient process that reduces delays and gives clients confidence and peace of mind.